Doctors & patients are saying about 'A-Fib.com'...

"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD

Doctors & patients are saying about 'Beat Your A-Fib'...

"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient,
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA

2026 AF Symposium: 3-Years Post-Ablation—Anticoagulants & Low-Risk Patients

Published March 17, 2026

A recurring theme at this year’s AF Symposium was anticoagulation after a successful catheter ablation for Atrial Fibrillation—a very important subject to us A-Fib patients. In the past, if you had a catheter ablation, you’ve been told that you now must be on anticoagulants for life.

Dr. Atul Verma (McGill Un. Health Center, Montreal, Canada) reported on the OCEAN trial—an insightful 3-year study on this topic.

The OCEAN Trial: At 56 different centers worldwide, 1,284 patients were enrolled. All patients had received catheter ablations and had remained A-Fib free for at least 1 year. Overall CHA2DS2-VASc stroke risk scores were low-to-intermediate for all patients.

Magnetic resonance imaging (MRI) is a non-invasive, radiation-free 3-D imaging technique used with A-Fib patients to assess post-ablation success, and evaluate stroke risk.

When the trial began, Magnetic Resonance Imaging (MRI) was used as to create a benchmark and again at follow-up 3 years later.

During the 3 year trial, one group received rivaroxaban (Xarelto) 15 mg daily. The second group received aspirin 75-120 mg. [Aspirin was used as it has negligible anti-stroke effects and is basically like taking a placebo.]

…Continue reading to learn the 3-years trial results about continuing anticoagulation for life->